SUZANNE JOHANNIGMAN: Open Payments
NPI 1811392483 · BATESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 34 payments from 13 companies in 2025. Trend: 2023 $745 · 2024 $108 · 2025 $564
Food & beverage: $540Education: $24
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $88 |
| Novo Nordisk Inc | 3 | $47 |
| Astellas Pharma US Inc | 2 | $42 |
| Exact Sciences Corporation | 2 | $38 |
| Lilly USA, LLC | 2 | $31 |
| Corium, LLC | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Biogen, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
Products named: FANAPT, TRINTELLIX, Veozah, Cologuard Collection Kit, Ozempic, MOUNJARO, Azstarys, ZURZUVAE.
Industry payments across IN — which companies pay providers there.
